acetaminophen has been researched along with 2-aminoethoxydiphenyl borate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bohr, S; Iracheta-Velle, A; Iracheta-Vellve, A; Jindal, R; King, KR; Li, M; Milwid, JM; Parekkadan, B; Patel, SJ; Vitalo, A; Yarmush, ML | 1 |
Du, K; Farhood, A; Jaeschke, H; McGill, MR; Vinken, M; Williams, CD; Xie, Y | 1 |
2 other study(ies) available for acetaminophen and 2-aminoethoxydiphenyl borate
Article | Year |
---|---|
Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure.
Topics: Acetaminophen; Animals; Boron Compounds; Chemical and Drug Induced Liver Injury; Connexins; Gap Junction beta-1 Protein; Gap Junctions; HeLa Cells; Humans; Liver Failure, Acute; Mice; Mice, Inbred C57BL; Protective Agents; Thioacetamide | 2012 |
The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activation.
Topics: Acetaminophen; Animals; Boron Compounds; Chemical and Drug Induced Liver Injury; Connexins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dimethyl Sulfoxide; Gap Junction beta-1 Protein; Gap Junctions; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; tert-Butylhydroperoxide | 2013 |